Cell-type specific oxytocin gene expression from aav delivered promoter deletion constructs into the rat supraoptic nucleus in vivo

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Fields, Raymond L ^a   Ponzio, Todd A ^a,b   Kawasaki, Makoto ^a,c   Gainer, Harold ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; ARGIPRESSIN; GREEN FLUORESCENT PROTEIN; OXYTOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL SPECIFICITY; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENE LOCATION; GENOME SIZE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MAGNOCELLULAR NEURON; MALE; MICROINJECTION; NONHUMAN; OXYTOCIN GENE; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REPORTER GENE; STEREOTACTIC PROCEDURE; SUPRAOPTIC NUCLEUS; TRANSCRIPTION INITIATION SITE; ADENO ASSOCIATED VIRUS; ANIMAL; ANTIBODY SPECIFICITY; CYTOLOGY; EXON; GENE DELETION; GENE TRANSFER; GENE VECTOR; GENETICS; INTRON; METABOLISM; OSMOSIS; REPRODUCIBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE VASOPRESSIN; DEPENDOVIRUS; EXONS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INTRONS; MALE; ORGAN SPECIFICITY; OSMOSIS; OXYTOCIN; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SEQUENCE DELETION; STEREOTAXIC TECHNIQUES; SUPRAOPTIC NUCLEUS;

EID: 84857412799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032085     Document Type: Article

References (76)

1. Nelson SB, Sugino K, Hempel CM, (2006) The problem of neuronal cell types: a physiological genomics approach. Trends Neurosci 29: 339-345.
2. Sugino K, Hempel CM, Miller MN, Hattox AM, Shapiro P, et al. (2006) Molecular taxonomy of major neuronal classes in the adult mouse forebrain. Nat Neurosci 9: 99-107.
3. Hokfelt T, Broberger C, Xu ZQ, Sergeyev V, Ubink R, et al. (2000) Neuropeptides-an overview. Neuropharmacology 39: 1337-1356.
4. Allan DW, St Pierre SE, Miguel-Aliaga I, Thor S, (2003) Specification of neuropeptide cell identity by the integration of retrograde BMP signaling and a combinatorial transcription factor code. Cell 113: 73-86.
5. Brownstein MJ, Russell JT, Gainer H, (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207: 373-378.
6. Burbach JP, Luckman SM, Murphy D, Gainer H, (2001) Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 81: 1197-1267.
7. Lee HJ, Macbeth AH, Pagani JH, Young WS III, (2009) Oxytocin: the great facilitator of life. Prog Neurobiol 88: 127-151.
8. Caldwell HK, Lee HJ, Macbeth AH, Young WS III, (2008) Vasopressin: behavioral roles of an "original" neuropeptide. Prog Neurobiol 84: 1-24.
9. Heinrichs M, von Dawans B, Domes G, (2009) Oxytocin, vasopressin, and human social behavior. Frontiers in neuroendocrinology 30: 548-557.
10. Insel TR, (2010) The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 65: 768-779.
11. Landgraf R, Neumann ID, (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Frontiers in neuroendocrinology 25: 150-176.
12. Armstrong WE, (1995) Morphological and electrophysiological classification of hypothalamic supraoptic neurons. Prog Neurobiol 47: 291-339.
13. Kiyama H, Emson PC, (1990) Evidence for the co-expression of oxytocin and vasopressin messenger ribonucleic acids in magnocellular neurosecretory cells: simultaneous demonstration of two neurohypophysin messenger ribonucleic acids by hybridization histochemistry. Journal of neuroendocrinology 2: 257-259.
14. Mezey E, Kiss JZ, (1991) Coexpression of vasopressin and oxytocin in hypothalamic supraoptic neurons of lactating rats. Endocrinology 129: 1814-1820.
15. Glasgow E, Kusano K, Chin H, Mezey E, Young WS, et al. (1999) Single cell reverse transcription-polymerase chain reaction analysis of rat supraoptic magnocellular neurons: neuropeptide phenotypes and high voltage-gated calcium channel subtypes. Endocrinology 140: 5391-5401.
16. Xi D, Kusano K, Gainer H, (1999) Quantitative analysis of oxytocin and vasopressin messenger ribonucleic acids in single magnocellular neurons isolated from supraoptic nucleus of rat hypothalamus. Endocrinology 140: 4677-4682.
17. Davies J, Waller S, Zeng Q, Wells S, Murphy D, (2003) Further delineation of the sequences required for the expression and physiological regulation of the vasopressin gene in transgenic rat hypothalamic magnocellular neurones. Journal of neuroendocrinology 15: 42-50.
18. Jeong SW, Castel M, Zhang BJ, Fields RL, Paras P, et al. (2001) Cell-specific expression and subcellular localization of neurophysin-CAT-fusion proteins expressed from oxytocin and vasopressin gene promoter-driven constructs in transgenic mice. Exp Neurol 171: 255-271.
19. Young WS, Renolds K, Shepard EA, Gainer H, Castel M, (1990) Cell-specific expression of the rat oxytocin gene in transgenic mice. J Neuroendocrinol 2: 917-925.
20. Fields RL, House SB, Gainer H, (2003) Regulatory domains in the intergenic region of the oxytocin and vasopressin genes that control their hypothalamus-specific expression in vitro. J Neurosci 23: 7801-7809.
21. Urabe M, Ding C, Kotin RM, (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Human gene therapy 13: 1935-1943.
22. Lo HR, Chao YC, (2004) Rapid titer determination of baculovirus by quantitative real-time polymerase chain reaction. Biotechnology progress 20: 354-360.
23. O'Reilly DR, Miller LK, Luckow A, (1994) Baculovirus Expression Vectors: A Laboratory Manual N.Y. Oxford University Press.
24. Smith RH, Levy JR, Kotin RM, (2009) A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Molecular therapy: the journal of the American Society of Gene Therapy 17: 1888-1896.
25. Negrete A, Yang LC, Mendez AF, Levy JR, Kotin RM, (2007) Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system. The journal of gene medicine 9: 938-948.
26. Paxinos G, Watson C, (1986) The Rat Brain in Stereotaxic Coordinates Orlando, FL Academic Press.
27. Ben-Barak Y, Russell JT, Whitnall MH, Ozato K, Gainer H, (1985) Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci 5: 81-97.
28. Whitnall MH, Key S, Ben-Barak Y, Ozato K, Gainer H, (1985) Neurophysin in the hypothalamo-neurohypophysial system. II. Immunocytochemical studies of the ontogeny of oxytocinergic and vasopressinergic neurons. J Neurosci 5: 98-109.
29. Mason MRJ, Ehlert EME, Eggers R, Pool CW, Hermening S, et al. (2010) Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Molecular therapy: the journal of the American Society of Gene Therapy 18: 715-724.
30. Snyder BR, Gray SJ, Quach ET, Huang JW, Leung CH, et al. (2011) Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum Gene Ther 22: 1129-1135.
31. Zincarelli C, Soltys S, Rengo G, Koch WJ, Rabinowitz JE, (2010) Comparative cardiac gene delivery of adeno-associated virus serotypes 1-9 reveals that AAV6 mediates the most efficient transduction in mouse heart. Clin Transl Sci 3: 81-89.
32. Knobloch S, Charlet A, Hoffmann LC, Eliava M, Khrulev S, et al. (2012) Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 73: 1-14.
33. Yue C, Mutsuga N, Sugimura Y, Verbalis J, Gainer H, (2008) Differential kinetics of oxytocin and vasopressin heteronuclear RNA expression in the rat supraoptic nucleus in response to chronic salt loading in vivo. J Neuroendocrinol 20: 227-232.
34. Gainer H, Jeong SW, Witt DM, Chin H, (1995) Strategies for cell biological studies in oxytocinergic neurons. Adv Exp Med Biol 395: 1-8.
35. Gainer H, (1998) Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons. Adv Exp Med Biol 449: 15-27.
36. Burger C, Nash K, Mandel RJ, (2005) Recombinant adeno-associated viral vectors in the nervous system. Human gene therapy 16: 781-791.
37. Lim ST, Airavaara M, Harvey BK, (2010) Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res 61: 14-26.
38. Osten P, Grinevich V, Cetin A, (2007) Viral vectors: a wide range of choices and high levels of service. Handb Exp Pharmacol pp. 177-202.
39. Papale A, Cerovic M, Brambilla R, (2009) Viral vector approaches to modify gene expression in the brain. J Neurosci Methods 185: 1-14.
40. van den Pol AN, Ozduman K, Wollmann G, Ho WS, Simon I, et al. (2009) Viral strategies for studying the brain, including a replication-restricted self-amplifying delta-G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi-like expression. J Comp Neurol 516: 456-481.
41. de Backer MW, Brans MA, Luijendijk MC, Garner KM, Adan RA, (2010) Optimization of adeno-associated viral vector-mediated gene delivery to the hypothalamus. Human gene therapy 21: 673-682.
42. Garza JC, Kim CS, Liu J, Zhang W, Lu XY, (2008) Adeno-associated virus-mediated knockdown of melanocortin-4 receptor in the paraventricular nucleus of the hypothalamus promotes high-fat diet-induced hyperphagia and obesity. The Journal of endocrinology 197: 471-482.
43. Chen H, McCarty DM, Bruce AT, Suzuki K, (1998) Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Ther 5: 50-58.
44. Geller SF, Ge PS, Visel M, Greenberg KP, Flannery JG, (2007) Functional promoter testing using a modified lentiviral transfer vector. Mol Vis 13: 730-739.
45. Kuroda H, Kutner RH, Bazan NG, Reiser J, (2008) A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer. The journal of gene medicine 10: 1163-1175.
46. Li C, Hirsch M, Carter P, Asokan A, Zhou X, et al. (2009) A small regulatory element from chromosome 19 enhances liver-specific gene expression. Gene Ther 16: 43-51.
47. Wang B, Li J, Fu FH, Chen C, Zhu X, et al. (2008) Construction and analysis of compact muscle-specific promoters for AAV vectors. Gene Ther 15: 1489-1499.
48. de Backer MW, Fitzsimons CP, Brans MA, Luijendijk MC, Garner KM, et al. (2010) An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector. BMC Neurosci 11: 81.
49. Doherty FC, Schaack JB, Sladek CD, (2011) Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellular neurosecretory neurons in the rat supraoptic nucleus. J Neurosci Methods 197: 238-248.
50. Hindmarch C, Yao S, Beighton G, Paton J, Murphy D, (2006) A comprehensive description of the transcriptome of the hypothalamoneurohypophyseal system in euhydrated and dehydrated rats. Proc Natl Acad Sci U S A 103: 1609-1614.
51. Mutsuga N, Shahar T, Verbalis JG, Xiang CC, Brownstein MJ, et al. (2005) Regulation of gene expression in magnocellular neurons in rat supraoptic nucleus during sustained hypoosmolality. Endocrinology 146: 1254-1267.
52. Miyata S, Nakashima T, Kiyohara T, (1994) Structural dynamics of neural plasticity in the supraoptic nucleus of the rat hypothalamus during dehydration and rehydration. Brain Res Bull 34: 169-175.
53. Zhang B, Glasgow E, Murase T, Verbalis JG, Gainer H, (2001) Chronic hypoosmolality induces a selective decrease in magnocellular neurone soma and nuclear size in the rat hypothalamic supraoptic nucleus. Journal of neuroendocrinology 13: 29-36.
54. Ivell R, Richter D, (1984) The gene for the hypothalamic peptide hormone oxytocin is highly expressed in the bovine corpus luteum: biosynthesis, structure and sequence analysis. EMBO J 3: 2351-2354.
55. Richter D, (1988) Molecular events in expression of vasopressin and oxytocin and their cognate receptors. Am J Physiol 255: F207-219.
56. Kim JK, Summer SN, Wood WM, Schrier RW, (1996) Osmotic and non-osmotic regulation of arginine vasopressin (AVP) release, mRNA, and promoter activity in small cell lung carcinoma (SCLC) cells. Mol Cell Endocrinol 123: 179-186.
57. Okazaki T, Ishikawa T, Nishimori S, Igarashi T, Hata K, et al. (1997) Hyperosmolarity-induced gene stimulation is mediated by the negative calcium responsive element. J Biol Chem 272: 32274-32279.
58. Coulson JM, Edgson JL, Marshall-Jones ZV, Mulgrew R, Quinn JP, et al. (2003) Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box. Biochem J 369: 549-561.
59. Ho MY, Murphy D, (2002) The vasopressin gene non-canonical Hogness box: effect on protein binding and promoter function. Mol Cell Endocrinol 186: 17-25.
60. Richard S, Zingg HH, (1990) The human oxytocin gene promoter is regulated by estrogens. J Biol Chem 265: 6098-6103.
61. Richard S, Zingg HH, (1991) Identification of a retinoic acid response element in the human oxytocin promoter. J Biol Chem 266: 21428-21433.
62. Walther N, Wehrenberg U, Brackmann B, Ivell R, (1991) Mapping of the bovine oxytocin gene control region: identification of binding sites for luteal nuclear proteins in the 5′ non-coding region of the gene. J Neuroendocrinol 3: 539-549.
63. Wehrenberg U, Ivell R, Jansen M, von Goedecke S, Walther N, (1994) Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc Natl Acad Sci U S A 91: 1440-1444.
64. Adan RA, Cox JJ, Beischlag TV, Burbach JP, (1993) A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol Endocrinol 7: 47-57.
65. Adan RA, Cox JJ, van Kats JP, Burbach JP, (1992) Thyroid hormone regulates the oxytocin gene. J Biol Chem 267: 3771-3777.
66. Adan RA, Walther N, Cox JJ, Ivell R, Burbach JP, (1991) Comparison of the estrogen responsiveness of the rat and bovine oxytocin gene promoters. Biochem Biophys Res Commun 175: 117-122.
67. Burbach JP, (2002) Regulation of gene promoters of hypothalamic peptides. Front Neuroendocrinol 23: 342-369.
68. Lopes da Silva S, Burbach JP, (1995) The nuclear hormone-receptor family in the brain: classics and orphans. Trends Neurosci 18: 542-548.
69. Chu K, Zingg HH, (1999) Activation of the mouse oxytocin promoter by the orphan receptor RORalpha. J Mol Endocrinol 23: 337-346.
70. Lipkin SM, Nelson CA, Glass CK, Rosenfeld MG, (1992) A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactivation domains. Proc Natl Acad Sci U S A 89: 1209-1213.
71. Ivell R, Bathgate RA, Walther N, Kimura T, (1998) The molecular basis of oxytocin and oxytocin receptor gene expression in reproductive tissues. Adv Exp Med Biol 449: 297-306.
72. Burbach JP, Lopes da Silva S, Cox JJ, Adan RA, Cooney AJ, et al. (1994) Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. J Biol Chem 269: 15046-15053.
73. Chu K, Zingg HH, (1997) The nuclear orphan receptors COUP-TFII and Ear-2 act as silencers of the human oxytocin gene promoter. J Mol Endocrinol 19: 163-172.
74. Sladek CD, Somponpun SJ, (2004) Oestrogen receptor beta: role in neurohypophyseal neurones. Journal of neuroendocrinology 16: 365-371.
75. Lopes da Silva S, Cox JJ, Jonk LJ, Kruijer W, Burbach JP, (1995) Localization of transcripts of the related nuclear orphan receptors COUP-TF I and ARP-1 in the adult mouse brain. Brain Res Mol Brain Res 30: 131-136.
76. Bradley DJ, Towle HC, Young WS III, (1992) Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci 12: 2288-2302.